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ABSTRACT. Four complexes of Mn(II), Co(II), Ni(II) and Cu(II) with Schiff base ligand (H3L) derived from 2-
amino-3-methylbutanoic acid and acetylacetonate were synthesized. All complexes were characterized by 
elemental analysis, Fourier-transform infrared spectroscopy and electronic spectroscopy. The results confirmed 
the coordination of the ligand to metals in tridentate fashion via the hydroxyl oxygen, the azomethine nitrogen and 
the enolic acetylacetonate oxygen. Antimicrobial activities were established for all complexes, free ligand and 
ciprofloxacin for comparison. Both the ligand and its metal complexes were active against Gram-positive and 
negative bacterial strains. The Cu(II) complex, showed highest antibacterial activity among the complexes 
screened. Other complexes displayed considerable antibacterial activity. Octahedral geometry was proposed for 
the metal(II) complexes with the Schiff base. 
  




Microbial resistance to antibiotics has become an issue of worldwide concern, which requires 
concerted efforts to address it [1, 2]. The infections caused by bacterial resistance to current 
available antibiotics are responsible for the alarming increasing high rate of mortality annually 
[3]. These antibiotic-resistant infections affect lives everyday causing a threat to health similar 
to influenza, tuberculosis and HIV combined [4-6]. Bacteria usually developed different 
resistance mode to overcome the extended spectrum of antibiotics [7], and the mechanism 
through which this resistance evolved as acknowledged by microbiologists, include enzymatic 
degradation by the lactamases, destruction of lactam ring and its re-configuration [8]. This has 
resulted to series of research which aimed at increasing the efficacy of the anti-microbial agent 
against the resistance micro-organisms. As a result, the necessity to design new agents for 
combating this resistance is of top most priority [9]. Transition metals ions have inherent 
advantages over the more common organic-based drugs. They can provide a wide range of 
coordination geometries, various redox states, ‘tunability’ of kinetics and thermodynamics of 
ligand substitution [10, 11]. Metal-based drugs play an essential role in medicine for the 
treatment of various diseases.  
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Amino acids are versatile bio-ligands for complex formations because they contain an 
important combination of carboxylic and amine groups. They are also a very good candidate for 
the Schiff bases condensation reactions, with an array of carbonyl compounds due to the 
presence of amine groups. These reactions have been shown to stabilize when aldehydes and 
amino acids can form two five membered rings chelated to the metal ion. It was suggested that 
atoms of amino acid will hold in the plane of the aromatic ring when they are coordinated to the 
metal ions [12]. Metal complexes derived from amino acids have attracted much more attention 
because of its inorganic and biological importance [13-15]. They show wide applications as 
anti-cancer, anti-tumor, anti-bacterial, anti-fungal, and anti-inflammatory agents [15-17]. The 
majority of work of amino acids Schiff-bases has been carried out on the aromatic aldehyde and 
its derivatives [18, 19]. 
In this manuscript, the synthesis, spectral characterization and antibacterial investigations of 
the new Mn(II), Co(II), Ni(II) and Cu(II) complexes of 2-amino-3-methylbutanoic acid (valine) 
and acetylacetone have been described. 
EXPERIMENTAL 
 
All the solvents and reagents were of analytical grade and were used as purchased from 
commercial sources. The metal chlorides were used as hydrated salts. CHN analyzer (Perkin-
Elmer 2400 model) was used to obtain the carbon, hydrogen and nitrogen contents. Fourier 
transform infrared spectra were measured on a Mattson 5000 FTIR spectrophotometer in the 
4000–400 cm-1 range using KBr pellets. Electronic spectra were recorded using JENWAY 6405 
UV-Vis spectrophotometer between 200-1100 nm by using suitable solvent. The MPA100 
Optimelt Automated Melting Point System (SRS) was used to obtain the melting points of the 
compounds. The antibacterial activities of the ligand and its metal complexes were carried out 
by well-diffusion method. The data obtained were analyzed using GraphPad Prism 8 (GraphPad 
Software Inc., San Diego, California, USA). Data are recorded as means of duplicate ± standard 
deviation (SD). 
 
Preparation of Schiff base 
 
The Schiff base ligand (H3L) was prepared by condensation of 2-amino-3-methylbutanoic acid 
(0.06 mmol) with acetylacetonate (0.06 mmol) in 20 mL of H2O/ethanol and the mixture was 
stirred for 4-5 h. K2CO3 (0.1% w/v in ethanol) was added to adjust the pH of the solution at 7-8. 
The precipitate was filtered, washed with ethanol and then ether to remove unreacted ligands, 
and then dried. The purity of ligand was checked by TLC and was then recrystallized from 
ethanol to obtain pale yellow crystalline solid (Figure 1). 
 
 
Figure 1. Synthetic route for the preparation of the Schiff base. 
Synthesis of metal(II) complexes 
The metal(II) complexes were prepared from four hydrated metal salts. 0.05 mol of ligand 
(H3L) in 20 mL of ethanol, was added to the 0.05 mmol of MCl2.xH2O (where, M 
=CuCl2.2H2O, NiCl2.6H2O, CoCl2.6H2O and MnCl2.4H2O) in ethanol solution. The mixture was 
stirred for 3-5 h and the precipitated colored complexes were filtrated, washed with water, 
ethanol and kept dry in a vacuum desiccator over anhydrous calcium chloride (Figure 2). 
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The synthesized Schiff base and metal complexes was tested in-vitro using clinical isolates of 
two Gram-negative (Escherichia coli and Staphylococcus aureus) and two Gram-positive 
(Klebsiella pneumonia and Pseudomonas aeruginosa) bacterial strains with sterile Muller–
Hinton nutrient agar as the medium. A 5 mm diameter well for each was dug in Muller Hinton 
agar using a cork borer. The ligand and complexes were dissolved separately in DMSO to have 
different concentrations (25 and 50 μg) per disc. The solution was carefully introduced into each 
well. The plates were incubated at 37 °C for 24 h. The clear inhibition zone around the well was 
determined and results measured (in mm). Ciprofloxacin was used as standard drug. 
 
RESULTS AND DISCUSSION 
 
A new series of Schiff base complexes, [M(H3L)(H2O)Cl2], (Mn(II), Ni(II), Co(II) and Cu(II)) 
have been derived from the  reaction of 2-amino-3-methylbutanoic acid and acetylacetonate in 
presence of respective metal salts. The compounds were stable in air and soluble in DMSO 
(dimethylsulfoxide) and DMF (dimethylformamide). Melting point values for the derived 
complexes ranges between 220-242 oC when compared to a relatively lower value of 204 oC for 
the ligand (Schiff base). The increased melting points can be due to the coordination of the 
ligand to the metal ions. The low values of molar conductance of the complexes in DMSO 
indicate the complexes are non-electrolyte nature, and are in affirmation of a neutral metal 
complex derived from dianionic ligand [20]. The complexes were all coloured which is a major 
characteristics of transition metal compounds. The results of the elemental analyses were in 
close agreement with the calculated values and hence confirm the stoichiometry of the 
compounds. The absorption peaks of electronic spectroscopy and characteristics bands of the 
infrared analysis, further ascertain the formation and geometry of the complexes. 
 














(ohm-1cm2mol-1)%C %H %N 
Schiff base 
C10H17NO3 
199.25 (199.12) 51.46 (51.48) 8.20 (8.21) 6.02 (6.00) 204 Off white 22.2 
Cu(II) complex 
C10H17Cl2NO4Cu 
347.98 (349.20) 34.35 (34.22) 4.90 (4.84) 4.01 (4.15) 220 Dark green 21.4 
Co(II) complex 
C10H17Cl2NO4Co 
343.99 (345.09) 34.80 (34.62) 4.97 (4.96) 4.06 (4.10) 242 Blue 20.6 
Ni(II) complex 
C10H17Cl2NO4Ni 
344.85 (342.98) 34.83 (35.13) 4.98 (5.12) 4.06 (4.08) 228 Gray 24.2 
Mn(II) complex 
C10H17Cl2NO4Mn 
341.09 (339.89) 35.21 (34.88) 5.02 (5.15) 4.11 (4.18) 238 Yellow 23.5 
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Infrared spectra of Schiff base metal complexes
 
The infrared spectra of Schiff base and metal complexes are shown in Figure 3. The 
data of the Schiff base and complexes are recorded in Table 2. The comparison of the ligand and 
complexes spectra serves as the basis of determining the coordination sites of the metal 
complexes [21]. The spectra bands 
of acac, were not present in the complexes, while there is presence of new band
azomethine group υ(C=N). The azomethine band seen
ligands. The metal complexes spectra display bands
from acac. The bands seen in range 1595
vibration [14]. The Schiff base behaves as a
the central metals through the enol fo
carboxylate oxygen (Figure 2). The assignments of the various bands in all the samples have 
been done in relation to similar compounds. The spectra are different from each other. The 
participation of the carboxylate group in bonding is supported by presence of bands observed at 
665 and 582 cm-1 [21]. Bands of the metal complexes shown in the regions 752
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Table 2. Infrared frequencies (in cm-1) of Schiff base ligand and complexes. 
 




) (OH) (M-O) (M-N) 
Schiff Base 3307 1654 1632 1584 1366 1055 - - 
Cu(II) complex 3379 1625 1614 1546 1384 1051 740 621 
Co(II) complex 3361 1652 1616 1595 1319 1074 752 605 
Ni(II) complex 3312 1635 1614 1568 1386 1010 738 621 
Mn(II) complex 3305 1631 1618 1556 1325 1026 751 623 
 
The involvement of deprotonated carboxylate and enolic carbonyl oxygen as well as the 
azomethine nitrogen in coordination is supported by the above findings. 
 
Electronic spectra of Schiff base metal complexes 
 
The UV-Vis electronic spectra are shown in Figure 4 and absorption data of all complexes are 
listed in Table 3. The Schiff base ligand showed two absorption bands in the UV regions. The 
absorptions at 270 nm and 290 nm ascribed to the π→π* transition is attributed for the intra-
ligand of aromatic system while the bands at 320 nm and 319 nm were respectively assigned to 
the n→π* transition for nitrogen atom of –NH2 and imine –N=C–group [28]. The electronic 
changes of these peaks which correspond to the Schiff base interaction with the metal ions are 





3T1g(P) transitions, respectively, in an octahedral geometry around 
Mn(II) ion in manganese(II) complexes were observed in spectra for 1 [23]. The Co(II) complex 






4T2g(P), respectively, suggesting an octahedral geometry [29]. 
Also the complex of Ni(II) present absorption peak at 629 nm which is expected for the 
3A2g→
3T2g transition, also the observed peak at 551 nm, is  related to 
3A2g→
3T1g(F), and signal 
at 467 nm is due to the 3A2g→
3T1g(P) transition indicating octahedral geometry [24]. Copper(II) 
complex showed broad peak at 614 nm assigned to 2B1g→
2A1g transition suggesting an 
octahedral geometry [25]. 
 
Table 3. Electronic spectra data of the Schiff base and its complexes. 
 
Compound λmax (nm) Assignment 
Schiff base 255 
355 
π → π* 
n → π* 
Cu(II) complex 250 
371 
604 
π → π* 
π → n* 
2B1g→
2A1g 




π → π* 










π → π* 











π → π* 
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Figiure 4. Electronic spectra of the ligand and its metal complexes
 
The data from spectral and analytical data suggests the modelled structure for the prepared 
complexes (Figure 5).  
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Antimicrobial studies of Schiff base metal complexes
 
The disc diffusion method was employed in screening the antibacterial potential of the
base and metal complexes against clinical isolates of S
Pseudomonas aeruginosa and 
of the prepared complexes are given in Table 4. The solvent and metal salt used showed no 
growth inhibition, suggesting they do not mediate in the antimicrobial activity of the synthesized 
complexes.  
 
Table 4. Results of antimicrobial screening of ligand and metal complexes
 
 
The complexes showed moderate to 
compared to the Schiff ligand and ciprofloxacin. As the concentration of the compounds 
increases there was increase in inhibitory activity. The activity of the ligand is enhanced upon 
complex formation, as shown by the data.
on the basis ofthe structures of 
resamination reactions mechanism in biological system. Ligands with oxygen and 
donor systems have been known to possibly inhibit enzyme production, since they require these 
groups for their activity to appear more prone to deactivation by the metal
coordination [26, 27]. Thus, we infer that complexation increases t
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Klebsiella pneumoniea. The results from the antibacterial studies 
. 
good antibacterial activity against the tested isolates as 
 The presence of the azomethine linkage is suggested 
H3L which is significant in explaining the transamination and 
nitrogen 
 ions upon 
he antimicrobial activity. 
 metal complexes. 
Inhibition zone diameter (mm) 
 E. coli P. aeruginosa K. pneumoniea 
Concentrations (mg/L) 
50 25 50 25 50 25 50 
20 20 22 22 22 18 18 
12 14 14 12 14 12 14 
16 16 16 16 18 14 16 
12 14 16 12 14 14 16 
14 14 14 14 16 12 14 

















Mn(II), Co(II), Ni(II), and Cu(II) complexes of amino acid derived Schiff base ligand 




A Schiff base ligand derived from acetylacetone and 2-amino-3-methylbutanoic acid and a 
series of its metal(II) complexes have been prepared and characterized by microanalysis and 
spectroscopic techniques. The prepared Schiff bases behaves as a tridentate ligand. The data 
from characterization studies confirm that the metal ions are coordinated to the hydroxyl and 
carbonyl oxygens and azomethine nitrogen atoms. The ligand and metal complexes were 
screened in vitro against five bacterial strains. All the compounds exhibited significant 
antibacterial inhibitory potential. The Cu(II) complex showed the best inhibitory activity against 
the bacterial P. aeruginosa when compared with other samples. Extended work could study the 
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